Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Other financing activities (2018 - 2026)

Alector's (ALEC) quarterly Other financing activities came in at $23000.0 in Q2 2026, down 81.15% year-over-year from $122000.0 in Q2 2025, and down 8.0% quarter-over-quarter from $25000.0 in Q1 2026.

Analysis

Alector (ALEC) Other financing activities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Other financing activities for 9 consecutive years, with $23000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other financing activities fell 81.15% year-over-year to $23000.0 in Q2 2026; TTM through Jun 2026 was $143000.0, a 72.55% decrease from a year earlier, with the FY2025 full-year figure at $217000.0, down 79.19% from the prior year.
  • Other financing activities was $23000.0 for Q2 2026 at Alector, down from $25000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $2.5 million in Q1 2022 and troughed at $23000.0 in Q2 2026.
  • A 5-year average of $486500.0 and a median of $257000.0 in 2023 frame the typical range for Other financing activities.
  • Across the five-year window, Other financing activities sank 99.41% in 2022 and soared 752.17% in 2023, its largest moves.
  • Over 5 years, Other financing activities stood at $46000.0 in 2022, then soared by 752.17% to $392000.0 in 2023, then advanced by 1.79% to $399000.0 in 2024, then tumbled by 76.19% to $95000.0 in 2025, then tumbled by 75.79% to $23000.0 in 2026.
  • The last three Other financing activities figures came in at $23000.0 (Q2 2026), $25000.0 (Q1 2026), and $95000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Alector 274.68 Mn 101.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23,000.00
Mar 31, 2026 25,000.00
Dec 31, 2025 95,000.00
Jun 30, 2025 122,000.00
Dec 31, 2024 399,000.00
Jun 30, 2024 644,000.00
Dec 31, 2023 392,000.00
Mar 31, 2023 1.08 Mn
Dec 31, 2022 46,000.00
Sep 30, 2022 489,000.00
Jun 30, 2022 41,000.00
Mar 31, 2022 2.48 Mn
Dec 31, 2021 7.84 Mn
Sep 30, 2021 14.82 Mn
Jun 30, 2021 1.99 Mn
Mar 31, 2021 3.87 Mn
Dec 31, 2020 632,000.00
Sep 30, 2020 286,000.00
Jun 30, 2020 2.20 Mn
Mar 31, 2020 3.22 Mn